Zum Hauptinhalt springen

Haarausfall

Zuletzt bearbeitet: Zuletzt revidiert:
Zuletzt revidiert von:


  1. Wolff H, Fischer TW, Blume-Peytavi U. Diagnostik und Therapie von Haar- und Kopfhauterkrankungen. Dtsch Ärztebl 2016; 113: 377-86. doi:10:3238/arztebl.2016.0377 www.aerzteblatt.de  
  2. Springer K, Brown M, Stulberg DL. Common hair loss disorders. Am Fam Physician 2003; 68: 93-102. PubMed  
  3. Blume-Peytavi U, Blumeyer A, Tosti A, Finner A, Marmol V, Trakatelli M, Reygagne P, Messenger A, and the European Consensus Group S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. British Journal of Dermatology. 2011;164(1):5-15. www.medscape.com  
  4. Blumeyer A, Tosti A, Messenger A, Reygagne P, del Marmol V, Spuls PI, Trakatelli M, Finner A, Kiesewetter F, Trüeb R, Rzany B, Ulrike Blume-Peytavi U. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. Volume 9, Issue Supplement s6, pages S1–S57, October 2011 onlinelibrary.wiley.com  
  5. Price VH. Treatment of hair loss. N Engl J Med 1999; 341: 964–973. www.ncbi.nlm.nih.gov  
  6. Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician 2009; 80: 356-62. American Family Physician  
  7. Sperling LC, Mezebish DS. Hair diseases. Med Clin North Am 1998;82:1155-69. PubMed  
  8. Habif TP. Clinical dermatology: a color guide to diagnosis and therapy. 3d ed. St. Louis: Mosby, 1996.
  9. Shapiro J, Price VH. Hair regrowth. Therapeutic agents. Dermatol Clin 1998;16:341-56. PubMed  
  10. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol 1996;35(3 pt 1):465-9. www.ncbi.nlm.nih.gov  
  11. Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 2002; 146: 992–9. www.ncbi.nlm.nih.gov  
  12. Raudrant D, Rabe T. Progestogens with antiandrogenic properties. Drugs 2003; 63: 463–92. www.ncbi.nlm.nih.gov  
  13. Wolff H, Haarausfall in der Praxis- Was tun?, Arzneiverordnung in der Praxis, Band 42, Heft 1 Januar 2015 www.akdae.de  
  14. arzneimitteltelegramm, a-t,PERSISTIERENDE SEXUELLE DYSFUNKTIONEN NACH FINASTERID, 2018; 49: 71-2 www.arznei-telegramm.de  
  15. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol 1996;35:539-42. PubMed  
  16. Elewski BE. Treatment of tinea capitis: beyond griseofulvin. J Am Acad Dermatol 1999;40(6 Pt 2):S27-30. www.ncbi.nlm.nih.gov  
  17. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. J Clin Psychiatry 1996;57(Suppl 8):42-7. www.ncbi.nlm.nih.gov  
  18. Jackson EA. Hair disorders. Prim Care 2000;27: 319-32. PubMed  
  19. Piérard GE, Piérard-Franchimont C, Marks R, Elsner P, for the EEMCO group (European Expert Group on Efficacy Measurement of Cosmetics and Other Topical Products). EEMCO guidance for the assessment of hair shedding and alopecia. Skin Pharmacol Physiol 2004; 17: 98–110. www.ncbi.nlm.nih.gov  
  20. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol 2002; 27: 389–95. onlinelibrary.wiley.com  
  21. Headington JT. Cicatricial alopecia. Dermatol Clin 1996;14:773-82. PubMed  
  22. Sperling LC. Hair and systemic disease. Dermatol Clin 2001;19:711-26. PubMed  
  • Heidrun Bahle, Dr.med., Fachärztin für Allgemeinmedizin, München
  • Marlies Karsch-Völk, Dr. med., Fachärztin für Allgemeinmedizin, München
  • Stefan Bösner, Prof. Dr. med., Facharzt für Allgemeinmedizin, Abteilung für Allgemeinmedizin, Präventive und Rehabilitative Medizin, Marburg (Review)
  • Lena Wanger, med dr och överläkare, Stockholm (Medibas)